Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
BT1718 BT1718 靶向药 - 癌症123
A Cancer Research UK phase I/IIa trial of BT1718 (a first in class ...
Bicycle Therapeutics to Present New Translational Data for BT1718 and ...
COA of BT1718 | Certificate of Analysis | AbMole BioScience
BT1718 – BICICI & COTY
BT1718 Purple Princess Puff Dress - A Royal Touch for Your Little Lady ...
Structures of BT1718, ICT2588 and Cy-SS-MTX. | Download Scientific Diagram
双环肽药物筛选引领者Bicycle Therapeutics_公司_合成_细胞
双环肽药物筛选引领者Bicycle Therapeutics-专栏+盘点-肽研社-为医疗健康企业专业解决方案
GRAPHIC
바이시클 테라퓨틱스, 美 IPO 통해 8625만弗 유치 - 바이오스펙테이터
Circling Back On Bicycle Therapeutics (NASDAQ:BCYC) | Seeking Alpha
PDC药物的靶向释放原理与代谢产物鉴定研究策略 - 知乎
Physiomics | Population PK and NCA
踩着“单车”治疗癌症，英国公司 B 轮融资 4000 万英镑 - 癌症123
探针资本_行业研究：多肽类药物_胰岛素
深受MNC青睐的双环肽(Bicycle)技术平台用于开发肿瘤新疗法 - 知乎
Bicycle Therapeutics and CRUK collaborate to take first-in-class ...
(PDF) Development of BT1718, a Bicycle Drug Conjugate® (BDC) targeting ...
What PDC products are under development? - Creative Peptides Blog
Bicycle Therapeutics Brings its First Anti-Cancer Peptide to the Clinic
Discovery of BT8009: A Nectin-4 Targeting Bicycle Toxin Conjugate for ...
Abstract 1167: Development of BT1718, a novel Bicycle Drug Conjugate ...
Bicycle Therapeutics：双环肽精准靶向潜力，有望使放射性偶联药物与ADC齐光_腾讯新闻
Bicycle Therapeutics - Bicycle Conjugates - Bicycle Therapeutics
Bicycle Therapeutics and Cancer Research UK Announce Initiation of ...
Bicycle Therapeutics to present on BT5528 - Cambridge Innovation Capital
Bicycle Therapeutics and Cancer Research UK launch first trial of a ...
Bicycle Therapeutics, Cancer Research UK collaborate on new immuno
Bicycle Therapeutics awarded best new drug developer of 2018 by World ...
Bicycle Therapeutics：新融资40亿多肽偶联药物引领者_摩熵医药(原药融云)
Bicycle Therapeutics Announces £40 Million ($52 Million) in Series B ...
BT-1718(BT-1718) - 药物靶点：MMP14 x MT1 x Tubulin_在研适应症：晚期恶性实体瘤，食管癌，鳞状非小细胞 ...
Bicycle announces first patient dosed in Phase IIa trial - Cambridge ...
Full article: Development of a Lc–Ms/Ms Method for the Quantification ...
ADC大火，那么PDC怎么样了？_药物_Bicycle_治疗
Polysarcosine in Pharmaceuticals: Applications, PEG Alternative and ADC ...
Bicycle Therapeutics：新融资40亿多肽偶联药物引领者_摩熵医药
BT8009 的发现：一种用于癌症治疗的靶向Nectin-4的双环毒素偶联物 - 知乎
CRUK research arm starts first-in-class Bicycle Therapeutics trial in ...
Bicycle Therapeutics on LinkedIn: "My dream would be able to bring new ...
BT1718: developing a first-in-class therapy in an award-winning ...
多肽偶联物（PDC）会是下一个风口？一文解读全球热点在研PDC及其技术 - 知乎
医药公司 Bicycle Therapeutics Limited 于 05月23号美股上市 - 知乎
Research Grade Anti-Human MMP14 (BT1718)价格_品牌:AntibodySystem-丁香通
Bicycle Therapeutics-Bicycle Therapeutics PLC-企业详情-InvestGO数据库-ByDrug ...
多肽类抗肿瘤药物类别盘点 - 脉脉
PDC新动态：Bicycle完成BT晚期实体瘤5528I/II研究扩展部分首位患者给药-试药员招聘与临床试验信息平台
Focus | 噬菌体展示技术——合成生物学的实力新星 - 知乎
PDC新动态：Bicycle 完成BT5528在EphA2 表达相关的晚期实体瘤I/II 期研究扩展部分首位患者给药|实体瘤|靶向|肿瘤|细胞 ...
多肽类抗肿瘤药物类别盘点 - 知乎
Bicycle Therapeutics signs cancer development deal with CRUK
Bicycle Therapeutics: Pedaling Through Uncertainty (NASDAQ:BCYC ...
Sudocetaxel Zendusortide进入I期临床，PDC重仓癌症治疗 - 知乎
PDC药物的靶向释放原理与代谢产物鉴定研究策略 - 药明康德DMPK
行业研究 | 双环肽Bicyclic Peptides: 肽类药物治疗的新前沿医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Next-Gen Drug Conjugates Bank €46M in Series B with American Investors
Nature-inspired and medicinally relevant short peptides
PDC：偶联多肽攻击实体瘤，国内有4家研发 | 研究院 近日，Oncopeptides公司开发的多肽偶联药物（peptide drug ...
BT1718;双环肽；一种针对MT1-MMP的双功能抗癌肽_细胞_肿瘤_mg
Better than ADCs? AstraZeneca bids for Bicyclic Peptides
BT1718；针对MT1-MMP的双功能抗癌肽；Cas: 2227366-66-5 - 知乎
Antibody drug conjugates in non-small cell lung cancer: An emerging ...
Bicyclic peptides: Paving the road for therapeutics of the future ...
PDC药物研究最新进展 - 知乎
BT1718；针对MT1-MMP的双功能抗癌肽；Cas: 2227366-66-5_细胞_肿瘤_模型
Bicyclic Peptides as Next‐Generation Therapeutics - Rhodes - 2017 ...
JMP Securities Reiterates Bicycle Therapeutics Plc - ADR (BCYC) Market ...
Development and Evaluation of [68Ga]Ga-DOTA-BT1718: A Novel Imaging ...
Bicyclic Peptides as Next-Generation Therapeutics. - Abstract - Europe PMC
多肽-药物偶联物抗癌，自行车上市 | 美中药源
新型多肽类与小分子PET显像剂：推动肿瘤精准诊疗的新前沿 - 知乎
